Previous close | 120.32 |
Open | 120.15 |
Bid | 0.00 x 900 |
Ask | 0.00 x 1000 |
Day's range | 118.94 - 121.79 |
52-week range | 79.92 - 133.56 |
Volume | |
Avg. volume | 3,717,095 |
Market cap | 145.408B |
Beta (5Y monthly) | 1.49 |
PE ratio (TTM) | 64.90 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 3.35 (2.72%) |
Ex-dividend date | 02 Feb 2024 |
1y target est | N/A |
Blackstone ( NYSE:BX ) First Quarter 2024 Results Key Financial Results Revenue: US$3.58b (up 177% from 1Q 2023). Net...
Blackstone's (BX) Q1 earnings meet estimates. The company reports a rise in AUM balance, which, along with a slight turnaround in the operating backdrop, supports top-line growth.
Private equity firm Blackstone Inc is nearing a deal to sell its controlling stake in South Korean wholesale drug distributor Geo-Young to North Asian buyout fund MBK Partners for over $1 billion, three sources said. Blackstone is in final negotiations with Seoul-headquartered MBK about the sale and signing of the deal could happen soon, said one of the sources, who all declined to be named as the information is confidential.